
    
      This non-interventional study assesses the real-life effectiveness, with focus on patient's
      quality of life, of the fixed triple therapy TrimbowÂ® after stepping up from a dual therapy
      in clinical practice at first line centres in patients with confirmed chronic obstructive
      pulmonary disease (COPD). Data will be collected on availability as per usual care at
      baseline, 3 and 6 months after inclusion.
    
  